Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Uncover various investment strategies designed to help you grow your wealth over time. Make informed investment decisions now.
13,834 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A rare market surge has happened only a handful of times since World War II. This article explains what that could me...
May payrolls showed solid gains, keeping the Fed on a cautious path. The strong data puts Warsh at odds with Trump on...
SPYI is delivering a near-12% yield year-to-date, but most distributions are classified as return of capital, which c...
Micron stock sinking today signals short-term selling pressure in a volatile memory market. This article breaks down ...
A former housing official pleads guilty to a mortgage fraud scheme that used forged documents to secure nearly $15 mi...
A surprise move from Berkshire Hathaway signals a broader embrace of technology bets. This article explains why Alpha...
Netcapital announces a nonbinding LOI to buy Resmac’s mortgage assets from RezyFi in a $5 million all-stock transacti...
Oracle stock drop today? sent shockwaves through the tech arena as investors weigh cloud strategy and AI momentum. Th...
Sweetgreen faced a sharp stock drop this week as traffic and cost pressures weighed on its growth story. This guide b...
As a new Fed chair, chair kevin warsh will confront two high-stakes tests in just 100 days. One test centers on polit...
The Columbia Research Enhanced Real Estate ETF (CRED) yields about 3.6% via pass-through REIT dividends. The fund’s i...